Showing results (401-410 of 433) with videos related to

Sort By:
Pageof 44
Clinical Chemistry|October 1, 2014
Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancerRui P L Neves, Katharina Raba, Oliver Schmidt, et al.
European Journal of Medicinal Chemistry|March 22, 2020
A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemiaAndreas Sellmer, Bernadette Pilsl, Mandy Beyer, et al.
Nature Communications|May 12, 2026
Gpnmb defines a phagocytic state of microglia linked to cell death in prion disease mouse modelDavide Caredio, Giovanni Mariutti, Lisa Polzer, et al.
International Journal of Cancer|June 2, 2025
Mass cytometric detection of homologous recombination proficiency in circulating tumor cells to predict chemoresistance of metastatic breast cancer patientsKathrin Niedermayer, Henning Schäffler, Georgios Vlachos, et al.
Mabs|May 28, 2016
Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodiesLindsay B Avery, Mengmeng Wang, Mania S Kavosi, et al.
Leukemia|September 13, 2017
Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemiaK Reiter, H Polzer, C Krupka, et al.
International Journal of Cancer|August 9, 2023
Ex vivo expansion of lung cancer-derived disseminated cancer cells from lymph nodes identifies cells associated with metastatic progressionSteffi Treitschke, Kathrin Weidele, Adithi Ravikumar Varadarajan, et al.
Clinical Neuropharmacology|July 4, 2014
Influence of the nonergot dopamine agonist piribedil on vigilance in patients With Parkinson Disease and excessive daytime sleepiness (PiViCog-PD): an 11-week randomized comparison trial against pramipexole and ropiniroleKarla Eggert, Christian Öhlwein, Jan Kassubek, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|March 26, 2025
Complex, low-intensity, individualised naturalistic developmental behavioural intervention in toddlers and pre-schoolers with autism spectrum disorder: The multicentre, observer-blind, parallel-group randomised-controlled A-FFIP trialChristine M Freitag, Marietta Kirchner, Lukas D Sauer, et al.
Hemasphere|May 14, 2026
CDK6 inactivation counteracts CALR-mutant-induced MPN evolution and sensitizes MPN stem cells to interferon-α treatmentBrian Ringhofer, Wolfram Polzer, Michaela Prchal-Murphy, et al.
Pageof 44